Posted on 1/25/18
Albireo Announces Proposed Public Offering of Common Stock
BOSTON, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today that . . .
Posted on 1/25/18
Ocular Therapeutix Announces Proposed Public Offering of Common Stock
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), today announced that it has commenced an underwritten public offering of its common stock pursuant to a shelf registration . . .
Posted on 1/24/18
Cigna Named a "Best Place to Work for LGBTQ Equality" for Sixth Year in a Row
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Cigna (NYSE: CI), a global health service company, received a perfect 100 score on the Human Rights Campaign's 2018 Corporate Equality Index (CEI) and . . .
Posted on 1/24/18
RXi Pharmaceuticals Regains Compliance with NASDAQ Listing Requirements
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company developing RNAi-based immunotherapies to treat cancer, today announced that it received a notice from the NASDAQ Stock Market . . .
Posted on 1/24/18
Synlogic Prices Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic (Nasdaq: SYBX) a clinical-stage company applying synthetic biology to probiotics to develop novel living medicines, today announced the pricing of its underwritten public . . .
Posted on 1/24/18
Boston Scientific Takes $90M Stake In Millipede With Option To Acquire
Boston Scientific (NYSE:BSX) completes a $90M investment in privately held Millipede, the developer of the IRIS Transcatheter Annuloplasty Ring System for the treatment of severe mitral . . .
Posted on 1/24/18
Agios Announces Closing of Public Offering
CAMBRIDGE, Mass., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO) today announced the closing of its previously announced underwritten public offering of common stock, . . .
Posted on 1/23/18
Synlogic Proposes Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic (Nasdaq: SYBX) a clinical-stage company applying synthetic biology to probiotics to develop novel living medicines, today announced that it has commenced an underwritten . . .
Posted on 1/23/18
HealthView Services and Mercy Launch Joint Venture Company HealthyCapital
HealthView Services, the country's leading provider of health care cost data to financial service firms, and Mercy, recognized as one of the top five performing health . . .
Posted on 1/23/18
BioCryst Pharmaceuticals' and Idera Pharmaceuticals' Merger Announcement Gets No Love
What happenedShares of both BioCryst Pharmaceuticals (NASDAQ:BCRX) and Idera Pharmaceuticals(NASDAQ:IDRA) plunged by as much as 12% and 28%, respectively, after the two announced that they were . . .
Posted on 1/22/18
Hale Family Makes $100 Million Philanthropic Investment in the Future of Medicine
Boston Children's Hospital (BCH) and Brigham and Women's Hospital (BWH) announce gifts of $50 million each from Rob and Karen Hale and their family to support . . .
Posted on 1/22/18
Top Physical Therapy Practice in the Country Brings Exceptional Patient Care to Watertown, MA
Professional Physical Therapy, Operating as ProEx Physical Therapy in New England, Expands Further in the Northeast Professional Physical Therapy, operating as ProEx Physical Therapy in the . . .
Posted on 1/22/18
Agios Announces Pricing of $475 Million Public Offering of Common Stock
CAMBRIDGE, Mass., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO) today announced that it has priced an underwritten public offering of 7,089,553 shares of . . .
Posted on 1/21/18
Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification
Check-Cap Ltd. (NASDAQ: CHEK, CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced that . . .
Posted on 1/21/18
FORTUNE Recognizes CVS Health on 2018 List of "World's Most Admired Companies"
CVS Health (NYSE: CVS), the nation's largest pharmacy innovation company, today was recognized by FORTUNE® magazine as one of the World's Most Admired Companies. CVS Health . . .
Posted on 1/19/18
Berkshire Without Buffett: Will It Flounder Without The Oracle At The Helm?
That old adage came to mind last week when I read of the latest internal moves at Berkshire Hathaway (BRK.A) (BRK.B). The company announced on January . . .
Posted on 1/19/18
Agios Prices $475 Million Public Offering of Common Stock
CAMBRIDGE, Mass., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO) today announced that it has priced an underwritten public offering of 7,089,553 shares of . . .
Posted on 1/19/18
Paratek Announces Pricing of Public Offering of Common Stock
BOSTON, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its . . .
Posted on 1/18/18
Genocea Biosciences Prices $55 Million Concurrent Public Offerings
CAMBRIDGE, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company that discovers and develops novel cancer vaccines, announced today the pricing . . .
Posted on 1/18/18
Paratek Announces Public Offering of Common Stock
BOSTON, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its . . .
Posted on 1/18/18
Agios Announces Proposed Offering of Common Stock
CAMBRIDGE, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO) today announced that it is offering to sell, subject to market and other conditions, . . .
Posted on 1/17/18
SchureMed Announces New Partnership with Professional Health Sales
SchureMed, Inc., a nationally recognized manufacturer of innovative and high quality surgical patient positioning equipment and devices is pleased to announce that they have entered into . . .
Posted on 1/17/18
X-Chem Enters Expanded Global Drug Discovery and Technology Transfer Collaboration with AstraZeneca
WALTHAM, Mass.--(BUSINESS WIRE)--Small molecule discovery specialist X-Chem, Inc. today announced a significant expansion of their existing global drug discovery collaboration with the global biopharmaceutical company AstraZeneca. . . .
Posted on 1/17/18
PathMaker Neurosystems Receives Award from Non-Profit Consortium
BOSTON--(BUSINESS WIRE)--PathMaker Neurosystems Inc., a clinical-stage bioelectronic medicine company developing non-invasive systems for the treatment of patients with neuromotor disorders, announced today that it is the . . .
Posted on 1/17/18
RXi Pharmaceuticals Announces Business Strategy
RXi Pharmaceuticals Corporation (NASDAQ: RXII) a clinical-stage company developing a new class of RNAi-based therapeutics outlined its 2018 business strategy during a webcast presentation at the . . .
Boston
